Penetrium Bioscience Inc
KOSDAQ:187660
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of Penetrium Bioscience Inc (187660) under the Base Case is KRW per share. Compared with the current market price of 5 890 KRW, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Penetrium Bioscience Does
ADM Korea is a contract research organization that helps drug makers run clinical trials in Korea. It supports the work needed to test new medicines, including trial planning, regulatory paperwork, site coordination, data handling, and study management. Its customers are pharmaceutical companies, biotech firms, and other drug developers that need help moving a medicine from development into human testing.
- Headquarters
- Korea KR
- Employees
- 160
- IPO date
- Jun 3, 2021
Earnings Waterfall
Penetrium Bioscience Inc
What is the Intrinsic Value of one Penetrium Bioscience Inc stock?
The intrinsic value for Penetrium Bioscience Inc (187660) under the Base Case is KRW.
Is Penetrium Bioscience Inc stock undervalued or overvalued?
Compared with the current market price of 5 890 KRW, the stock appears .